NYMOX PHARMACEUTICAL CORPORATION Total Liabilities
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) had Total Liabilities of $7.43 million as of 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Notes
ifrs-full:Liabilities · last filed 2025-06-03
- 2024-12-31: Liabilities $7.43M.
- 2024-09-30: Liabilities $6.92M.
- 2023-12-31: Liabilities $3.80M.
- 2023-09-30: Liabilities $2.57M.
| Period end | Liabilities |
|---|---|
| 2024-12-31 | $7.43M 20-F · filed 2025-06-03 |
| 2024-09-30 | $6.92M 6-K · filed 2025-01-02 |
| 2023-12-31 | $3.80M 20-F · filed 2025-06-03 |
| 2023-09-30 | $2.57M 6-K · filed 2023-11-15 |
| 2023-06-30 | $3.15M 6-K · filed 2023-08-14 |
| 2023-03-31 | $2.37M 6-K · filed 2023-05-12 |
| 2022-12-31 | $2.11M 20-F · filed 2024-08-29 |
| 2022-09-30 | $2.37M 6-K/A · filed 2022-11-16 |
| 2022-06-30 | $2.24M 6-K · filed 2022-08-15 |
| 2022-03-31 | $2.63M 6-K · filed 2022-05-13 |
| 2021-12-31 | $1.95M 20-F · filed 2023-05-02 |
| 2021-09-30 | $2.27M 6-K · filed 2021-11-12 |
| 2021-06-30 | $1.96M 6-K · filed 2021-08-13 |
| 2021-03-31 | $1.47M 6-K · filed 2021-05-14 |
| 2020-12-31 | $2.20M 20-F · filed 2022-03-30 |
| 2020-09-30 | $1.90M 6-K · filed 2020-11-13 |
| 2020-06-30 | $2.12M 6-K · filed 2020-08-14 |
| 2020-03-31 | $1.93M 6-K · filed 2020-05-14 |
| 2019-12-31 | $2.04M 20-F · filed 2022-03-30 |
| 2019-09-30 | $1.81M 6-K · filed 2019-11-13 |
| 2019-06-30 | $1.95M 6-K · filed 2019-08-14 |
| 2019-03-31 | $1.71M 6-K · filed 2019-05-15 |
| 2018-12-31 | $1.07M 20-F · filed 2021-03-29 |
| 2018-09-30 | $849.00K 6-K · filed 2018-11-13 |
| 2018-06-30 | $1.61M 6-K · filed 2018-08-13 |
| 2018-03-31 | $2.00M 6-K · filed 2018-05-15 |
| 2017-12-31 | $2.23M 20-F · filed 2020-03-30 |
| 2016-12-31 | $2.30M 20-F · filed 2019-03-29 |
| 2015-12-31 | $3.06M 20-F · filed 2018-03-30 |